Trial Profile
Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2017
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary)
- Indications Alcohol withdrawal; Substance-related disorders
- Focus Therapeutic Use
- 13 Feb 2017 Status changed from active, no longer recruiting to completed.
- 07 Dec 2016 Planned End Date changed from 1 Jan 2017 to 1 Dec 2016.
- 07 Dec 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2016.